EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM |
| Type de publication | Journal Article |
| Year of Publication | 2021 |
| Auteurs | Peterlin P., Turlure P., Chevallier P., Gourin M.-P, Dumas P.-Y, Thepot S., Berceanu A., Park S., Hospital M.-A, Cluzeau T., Torregrossa-Diaz J.-M, Devron L., Sapena R., Chermat F., Dimicoli-Salazar S., Fenaux P. |
| Journal | LEUKEMIA RESEARCH |
| Volume | 108 |
| Pagination | S46 |
| Date Published | SEP |
| Type of Article | Meeting Abstract |
| ISSN | 0145-2126 |